Aumolertinib showed improved PFS in NSCLC and ivonescimab outperforms pembrolizumab in advanced cases. Plus, insights into CAR T-cell therapy and its associated AEs are discussed in relapsed multiple ...

including scientists at MSD – known as Merck & Co in North America – which collaborated with the International Space Station (ISS) National Laboratory to generate crystallised versions of ...

We recently compiled a list of the 8 Unstoppable Stocks That Could Make You Richer. In this article, we are going to take a ...

Among patients with early triple-negative breast cancer, treatment with Keytruda (pembrolizumab) demonstrated real-world evidence of immune-related adverse effects (irAEs) comparable with KEYNOTE-522, ...

Keytruda (pembrolizumab) is a prescription drug that’s used to treat certain forms of cancer. Keytruda comes as an intravenous (IV) infusion (an injection into your vein given over time ...

KEYNOTE-689 trial showed significant improvement in event-free survival for stage 3 or 4A resected head and neck squamous cell carcinoma with Keytruda. Keytruda regimen included neoadjuvant therapy, ...

"We are planning our next set ... early next year," Bill Spetch, operations and integration manager of NASA’s International Space Station (ISS) program, said of spacewalks during a press ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless ...

The leak has been ongoing since 2019 in the Russian segment of the International Space Station (ISS) and was the focus of a new report from NASA's Office of the Inspector General (OIG) published ...

From holes in robotic arm to cracks in the window, astronauts have been complaining about the state of the International Space Station (ISS) for years. A NASA report this week admitted that ...